When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MOR - MorphoSys' tafasitamab added to U.S. treatment guidelines for type of blood cancer
MorphoSys AG
MorphoSys AG (NASDAQ:MOR) and collaborator/licensee Incyte (NASDAQ:INCY) announce that Monjuvi (tafasitamab-cxix) has been added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology for B-cell lymphomas.
More news on: MorphoSys AG, Incyte Corporation, Healthcare stocks news,